Five-year Follow-Up of Patients With Early Stage Breast Cancer After a Randomized Study Comparing Additional Treatment With Viscum Album (L.) Extract to Chemotherapy Alone

This 2012 randomized controlled trial (Breast Cancer: Basic and Clinical Research, PMID: 23150723) evaluated the five-year outcomes of adding Viscum album L. (mistletoe extract) to standard chemotherapy in patients with early-stage breast cancer. The study found that patients receiving the combination therapy experienced statistically significant improvements in overall survival and